EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC-ND 4.0

Protocol for generation and utilization of patient-derived organoids from multimodal specimen

Sumin Kang, Mi Rim Lee, Wonyoung Choi, Sun-Young Kong, Yun-Hee Kim

STAR Protocols · 2025-09 · 6 (3) · 104039

DOI: 10.1016/j.xpro.2025.104039 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift STAR Protocols, 2025-09. Verfasst von Sumin Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging Branch, Division of Convergence Technology, Research Institute of National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang, Gyeon…. Hauptthemen laut MEDLINE: Organoids, Cell Culture Techniques. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, National Cancer Center, Military Institute of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patient-derived organoids (PDOs) are robust preclinical models for precision oncology. However, most existing protocols depend on surgically resected specimens, limiting their applicability to patients who are ineligible for surgery. Here, we present a protocol for generating PDOs from various clinically accessible specimens-including biopsies (endoscopic ultrasound-guided fine needle biopsy [EUS-FNB], percutaneous liver biopsy [PLB], ascites, and pleural effusion)-across cancer types. We describe steps for specimen transport, tumor cell isolation, culture, biobanking, and high-throughput drug screening, supporting reproducible PDO applications in translational research across diverse clinical settings. For complete details on the use and execution of this protocol, please refer to Lee et al.1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsCell Culture TechniquesHumansNeoplasmsHigh-Throughput Screening AssaysLiverPrecision Medicine

Stichwörter der Autor:innen

CancerCell BiologyCell cultureCell isolationCell-based AssaysClinical ProtocolHigh-Throughput ScreeningMolecular BiologyOrganoids

Autor:innen und Institutionen

  • Molecular Imaging Branch, Division of Convergence Technology, Research Institute of National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang, Gyeonggi-do 10408, Republic of Korea; Department of Cancer Biomedical Scien…
  • Molecular Imaging Branch, Division of Convergence Technology, Research Institute of National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang, Gyeonggi-do 10408, Republic of Korea.
  • Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, 323 Ilsan-ro, Ilsandong-gu, Goyang, Gyeonggi-do 10408, Republic of Korea; Center for Clinical Trials, Researc…
  • Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, 323 Ilsan-ro, Ilsandong-gu, Goyang, Gyeonggi-do 10408, Republic of Korea; Targeted Therapy Branch, Division o…

Förderung

  • National Research Foundation of Korea
  • National Cancer Center
  • Military Institute of Science and Technology

Zitieren

APA

Kang, S., Lee, M. R., Choi, W., Kong, S. Y., & Kim, Y. H. (2025). Protocol for generation and utilization of patient-derived organoids from multimodal specimen. STAR Protocols, 6(3), 104039. https://doi.org/10.1016/j.xpro.2025.104039

Vancouver

Kang S, Lee MR, Choi W, Kong SY, Kim YH. Protocol for generation and utilization of patient-derived organoids from multimodal specimen. STAR Protocols. 2025;6(3):104039. doi:10.1016/j.xpro.2025.104039

BibTeX
@article{Kang2025,
  author = {Kang, Sumin and Lee, Mi Rim and Choi, Wonyoung and Kong, Sun-Young and Kim, Yun-Hee},
  title = {Protocol for generation and utilization of patient-derived organoids from multimodal specimen},
  journal = {STAR Protocols},
  year = {2025},
  volume = {6},
  number = {3},
  pages = {104039},
  doi = {10.1016/j.xpro.2025.104039}
}
Kostenlos starten →